CRMD CorMedix
- 8.570
- -0.300-3.38%
- 8.750
- +0.180+2.10%
CorMedix News
CorMedix Price Target Raised to $12 From $11 at RBC Capital
RBC Capital Maintains Outperform on Cormedix, Raises Price Target to $12
CorMedix Added to Nasdaq Biotechnology Index
CorMedix Inc. Added to Nasdaq Biotechnology Index
Is CorMedix Inc. (CRMD) Among Billionaire Paul Singer's Top Long-Term Stock Picks?
Express News | CorMedix Inc : RBC Raises Target Price to $12 From $11
CORMEDIX INC. ADDED TO NASDAQ BIOTECHNOLOGY INDEX
Investors Appear Satisfied With CorMedix Inc.'s (NASDAQ:CRMD) Prospects
CorMedix Set for Market Growth With Policy Changes and Strategic Partnerships Boosting DefenCath Adoption
CorMedix Inc. Supports CMS Policy Updates Regarding Access to Innovative Drug Products
CORMEDIX INC. SUPPORTS CMS POLICY UPDATES REGARDING ACCESS TO INNOVATIVE DRUG PRODUCTS
CorMedix Approves Key Governance and Incentive Changes
Here's Why We Think CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Looks Fair for the Time Being
CorMedix Inc. to Participate in the Truist Securities BioPharma Symposium
Rainbows and Unicorns: CorMedix Inc. (NASDAQ:CRMD) Analysts Just Became A Lot More Optimistic
CorMedix Inc. (NASDAQ:CRMD) Just Reported Third-Quarter Earnings And Analysts Are Lifting Their Estimates
While Shareholders of CorMedix (NASDAQ:CRMD) Are in the Black Over 1 Year, Those Who Bought a Week Ago Aren't so Fortunate
Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating
Cormedix Analyst Ratings
Express News | CorMedix Inc : RBC Raises Target Price to $11 From $9
No Data